Filing Details

Accession Number:
0001209191-14-062657
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-09 16:41:33
Reporting Period:
2014-10-07
Filing Date:
2014-10-09
Accepted Time:
2014-10-09 16:41:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496671 Calithera Biosciences Inc. CALA Pharmaceutical Preparations (2834) 272366329
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1316252 E Ralph Christoffersen 2710 Sand Hill Road, Suite 100
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-07 1,811,915 $0.00 1,811,915 No 4 C Indirect By Partnership
Common Stock Acquisiton 2014-10-07 350,000 $10.00 2,161,915 No 4 P Indirect By Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Partnership
No 4 P Indirect By Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock SERIES A PREFERRED STOCK Acquisiton 2014-10-07 10,999 $0.00 10,999 $0.00
Common Stock SERIES B PREFERRED STOCK Acquisiton 2014-10-07 419,181 $0.00 419,181 $0.00
Common Stock SERIES C PREFERRED STOCK Acquisiton 2014-10-07 747,540 $0.00 747,540 $0.00
Common Stock SERIES D PREFERRED STOCK Acquisiton 2014-10-07 634,195 $0.00 634,195 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately upon consummation of Issuer's initial public offering of Common Stock and had no expiration date.
  2. The securities are held by Morgenthaler Venture Partners IX, L.P. (MVP IX). The managing partner of MVP IX is Morgenthaler Management Partners IX, LLC (MMP IX). Ralph E. Christoffersen, a director of the Issuer is a Member of MMP IX. As such, the Reporting Person shares voting and investment power over the securities held by MMP IX. The Reporting Person disclaims beneficial ownership of the securities held by MMP IX except to the extent of his pecuniary interest therein.